Recent ASND News
- Ascendis Pharma Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/02/2024 08:01:00 PM
- Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024 • GlobeNewswire Inc. • 04/25/2024 08:46:31 PM
- United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism • GlobeNewswire Inc. • 04/24/2024 12:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 04:31:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 02:39:29 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 01:14:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 01:04:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 12:37:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 08:17:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 08:07:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 07:54:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 07:36:16 PM
- Ascendis Pharma to Participate in the Leerink Partners Global Biopharma Conference 2024 • GlobeNewswire Inc. • 03/04/2024 01:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 04:00:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/29/2024 10:13:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/28/2024 09:49:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2024 10:45:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2024 08:17:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 10:16:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 10:15:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 10:14:38 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/14/2024 09:07:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/14/2024 04:40:46 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:17:03 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM